CLL/SLL

Assist. Prof. Matthew Davids | ASH 2017 | iFCR incorporated into armamentarium for treatment of CLL

L:

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA

Assistant Professor Matthew Davids
Dana-Farber/Harvard Cancer Center, Boston, US

Interview Topic: How do you see iFCR being incorporated into the armamentarium for the treatment of CLL?